Purchases and Sales Made in Q4 2024 in Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX) during Q4 2024. The information is specifically focused on institutions that hold shares of Royalty Pharma plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2025
Q4 2024
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-354K- 64.35% |
$8.61M - $10.1M
|
196K
$6.56M
|
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-479K- 15.38% |
$11.6M - $13.6M
|
2.63M
$88M
|
|
|
Jan 06, 2025
Q4 2024
|
Nordea Investment Management Ab
Stockholm, V7 |
SELL
|
- |
-551K- 95.2% |
$13.4M - $15.6M
|
27.8K
$929K
|
|
|
Feb 12, 2025
Q4 2024
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-720K- 51.81% |
$17.5M - $20.5M
|
670K
$22.4M
|
|
|
Feb 12, 2025
Q4 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-921K- 63.06% |
$22.4M - $26.1M
|
539K
$18M
|
|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-1.05M- 95.44% |
$25.4M - $29.7M
|
50K
$1.67M
|
|
|
Feb 07, 2025
Q4 2024
|
Amundi
Paris, I0 |
SELL
|
- |
-1.14M- 30.81% |
$27.6M - $32.3M
|
2.55M
$85.4M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.55M- 3.76% |
$37.5M - $43.9M
|
39.5M
$1.32B
|
|
|
Feb 14, 2025
Q4 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.73M- 98.06% |
$42M - $49.1M
|
34.2K
$1.14M
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.93M- 44.37% |
$46.8M - $54.7M
|
2.42M
$80.7M
|
|
|
Jan 31, 2025
Q4 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-1.99M- 12.33% |
$48.3M - $56.4M
|
14.1M
$472M
|